XML 38 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities    
Net income $ 16,404,000 $ 12,690,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Net discount accretion (2,898,000) (1,594,000)
Depreciation and amortization expense 4,980,000 3,970,000
Impairment of intangibles 153,000 0
Provision for loan losses 5,025,000 900,000
Share-based compensation 1,613,000 1,154,000
Gain on sales of loans originated for sale (4,028,000) (1,653,000)
Mortgage loans originated for sale (147,647,000) (78,242,000)
Proceeds from sales of loans originated for sale 146,890,000 75,276,000
Gain on sale of portfolio loans (2,803,000) 0
Net loss (gain) on disposal of OREO 164,000 (8,000)
Writedown of OREO 544,000 0
Net loss on disposal of premises and equipment 1,000 137,000
Deferred income taxes (672,000) 1,348,000
Investment securities losses (gains) 44,000 (4,731,000)
Income from life insurance (1,615,000) (1,505,000)
(Increase) decrease in accrued interest receivable (2,772,000) 742,000
Decrease in accrued interest payable and other liabilities (504,000) (5,618,000)
Other, net 3,459,000 589,000
Net cash provided by operating activities 16,338,000 3,455,000
Cash flows from investing activities    
Proceeds from sales of AFS securities 0 199,411,000
Maturities, repayments and calls of AFS securities 38,970,000 22,934,000
Purchases of AFS securities (26,691,000) (166,694,000)
Net cash and cash equivalents received from acquisitions 0 29,442,000
Net redemptions of restricted investments in bank stocks 3,538,000 2,101,000
Net decrease in loans 65,605,000 4,023,000
Proceeds from sales of portfolio loans 22,665,000 0
Purchases of bank premises and equipment (914,000) (3,226,000)
Proceeds from disposal of OREO 3,734,000 724,000
Proceeds from disposal of bank premises and equipment 59,000 0
Purchases of bank owned life insurance (3,636,000) (2,280,000)
Death benefit proceeds from life insurance contracts 0 571,000
Net cash provided by investing activities 103,330,000 87,006,000
Cash flows from financing activities    
Net decrease in deposits (63,761,000) (23,598,000)
Net decrease in borrowings with original maturities less than 90 days (137,424,000) (2,464,000)
Proceeds from FHLB advances and other borrowings 180,955,000 20,000,000
Payments on FHLB advances and other borrowings (60,649,000) (116,678,000)
Subordinated note issuance costs 0 (59,000)
Dividends paid (5,712,000) (4,472,000)
Acquisition of treasury stock (1,170,000) 0
Treasury shares repurchased for employee taxes associated with restricted stock vesting (679,000) (1,694,000)
Proceeds from issuance of employee stock purchase plan shares 116,000 113,000
Net cash used in financing activities (88,324,000) (128,852,000)
Net increase (decrease) in cash and cash equivalents 31,344,000 (38,391,000)
Cash and cash equivalents at beginning of period 55,963,000 88,815,000
Cash and cash equivalents at end of period 87,307,000 50,424,000
Cash paid during the period for:    
Interest 13,387,000 17,573,000
Supplemental schedule of noncash investing activities:    
OREO acquired in settlement of loans 0 161,000
Lease liabilities arising from obtaining ROU assets 400,000 8,115,000
SBA PPP loans originated $ 467,654,000 $ 0